JANE STREET GROUP, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,072,836
+68.7%
177,317
+94.0%
0.00%
Q2 2023$1,228,497
-27.7%
91,406
-10.8%
0.00%
-100.0%
Q1 2023$1,698,919
+111.0%
102,468
+136.7%
0.00%
Q4 2022$805,324
+376.5%
43,297
+228.8%
0.00%
Q3 2022$169,0000.0%13,170
-45.5%
0.00%
Q2 2022$169,000
-80.2%
24,145
-76.5%
0.00%
Q1 2022$852,000
+616.0%
102,770
+482.8%
0.00%
Q4 2021$119,000
-38.7%
17,633
-51.9%
0.00%
Q3 2021$194,000
-62.1%
36,624
-58.9%
0.00%
Q2 2021$512,000
+369.7%
89,012
+172.6%
0.00%
Q4 2020$109,000
-77.7%
32,654
-80.2%
0.00%
Q3 2020$489,000
+652.3%
164,702
+1079.7%
0.00%
Q2 2020$65,000
-50.8%
13,961
-43.7%
0.00%
Q3 2019$132,000
+80.8%
24,776
+32.4%
0.00%
Q4 2017$73,000
+21.7%
18,720
-22.0%
0.00%
Q3 2017$60,000
+27.7%
23,999
-63.4%
0.00%
Q2 2016$47,000
-69.3%
65,594
+42.5%
0.00%
-100.0%
Q3 2014$153,00046,0390.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders